
Taeyoon Kim
Examiner (ID: 4325, Phone: (571)272-9041 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1631, 1632 |
| Total Applications | 1176 |
| Issued Applications | 467 |
| Pending Applications | 170 |
| Abandoned Applications | 584 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19081861
[patent_doc_number] => 20240108662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/039387
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039387
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039387 | ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF | Nov 22, 2021 | Pending |
Array
(
[id] => 17444088
[patent_doc_number] => 20220064593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS RELATING TO PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/526885
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/526885 | METHODS RELATING TO PLURIPOTENT CELLS | Nov 14, 2021 | Pending |
Array
(
[id] => 17444088
[patent_doc_number] => 20220064593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS RELATING TO PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/526885
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/526885 | METHODS RELATING TO PLURIPOTENT CELLS | Nov 14, 2021 | Pending |
Array
(
[id] => 17867372
[patent_doc_number] => 20220290108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/510717
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17510717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/510717 | OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM | Oct 25, 2021 | Abandoned |
Array
(
[id] => 18511616
[patent_doc_number] => 20230227786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => PREPARATION METHOD AND RECOVERY METHOD OF PARIDUVAL MESENCHYMAL STEM CELLS (PMSCs)
[patent_app_type] => utility
[patent_app_number] => 18/009473
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009473 | PREPARATION METHOD AND RECOVERY METHOD OF PARIDUVAL MESENCHYMAL STEM CELLS (PMSCs) | Oct 21, 2021 | Pending |
Array
(
[id] => 17383905
[patent_doc_number] => 20220031757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHOD FOR REPAIRING DAMAGED TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/503756
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503756 | METHOD FOR REPAIRING DAMAGED TISSUE | Oct 17, 2021 | Abandoned |
Array
(
[id] => 17519397
[patent_doc_number] => 20220105245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => BONE-LIKE PROSTHETIC IMPLANTS
[patent_app_type] => utility
[patent_app_number] => 17/500341
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500341 | BONE-LIKE PROSTHETIC IMPLANTS | Oct 12, 2021 | Abandoned |
Array
(
[id] => 17370279
[patent_doc_number] => 20220025331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/496391
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496391 | METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY | Oct 6, 2021 | Pending |
Array
(
[id] => 19186253
[patent_doc_number] => 20240165166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE
[patent_app_type] => utility
[patent_app_number] => 18/043064
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043064
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043064 | PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE | Sep 29, 2021 | Pending |
Array
(
[id] => 19186253
[patent_doc_number] => 20240165166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE
[patent_app_type] => utility
[patent_app_number] => 18/043064
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043064
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043064 | PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE | Sep 29, 2021 | Pending |
Array
(
[id] => 18771123
[patent_doc_number] => 20230365933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING STEM CELL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/246710
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246710 | COMPOSITIONS AND METHODS FOR INCREASING STEM CELL FUNCTION | Sep 27, 2021 | Pending |
Array
(
[id] => 18752376
[patent_doc_number] => 20230355608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => TARGETING POLYCYTHEMIA VERA (PV)-INITIATING CELLS BY BLOCKING LEUKOTRIENE BINDING TO THEIR RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 18/028991
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13718
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028991 | TARGETING POLYCYTHEMIA VERA (PV)-INITIATING CELLS BY BLOCKING LEUKOTRIENE BINDING TO THEIR RECEPTORS | Sep 23, 2021 | Pending |
Array
(
[id] => 17790608
[patent_doc_number] => 20220249699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMPOSITIONS AND METHODS FOR mRNA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/472622
[patent_app_country] => US
[patent_app_date] => 2021-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472622 | COMPOSITIONS AND METHODS FOR mRNA DELIVERY | Sep 10, 2021 | Pending |
Array
(
[id] => 17759208
[patent_doc_number] => 20220232820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => CRYOPRESERVATION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/469553
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/469553 | CRYOPRESERVATION METHOD | Sep 7, 2021 | Abandoned |
Array
(
[id] => 17314817
[patent_doc_number] => 20210403865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => LIVE CELL CONSTRUCTS FOR PRODUCTION OF CULTURED MILK PRODUCT AND METHODS USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/467358
[patent_app_country] => US
[patent_app_date] => 2021-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467358
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467358 | LIVE CELL CONSTRUCTS FOR PRODUCTION OF CULTURED MILK PRODUCT AND METHODS USING THE SAME | Sep 5, 2021 | Abandoned |
Array
(
[id] => 18656177
[patent_doc_number] => 20230302056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => ALLOGENEIC COMPOSITION FOR THE TREATMENT OF COVID-19
[patent_app_type] => utility
[patent_app_number] => 18/041507
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041507
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041507 | ALLOGENEIC COMPOSITION FOR THE TREATMENT OF COVID-19 | Aug 12, 2021 | Pending |
Array
(
[id] => 18656177
[patent_doc_number] => 20230302056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => ALLOGENEIC COMPOSITION FOR THE TREATMENT OF COVID-19
[patent_app_type] => utility
[patent_app_number] => 18/041507
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041507
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041507 | ALLOGENEIC COMPOSITION FOR THE TREATMENT OF COVID-19 | Aug 12, 2021 | Pending |
Array
(
[id] => 18895491
[patent_doc_number] => 20240010976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHODS AND COMPOSITIONS FOR STIMULATING GAMMA DELTA T CELLS
[patent_app_type] => utility
[patent_app_number] => 18/021144
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021144
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021144 | METHODS AND COMPOSITIONS FOR STIMULATING GAMMA DELTA T CELLS | Aug 11, 2021 | Pending |
Array
(
[id] => 18737943
[patent_doc_number] => 20230346845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => USES OF MSC IN IMPROVING THROMBOTIC COMPLICATIONS IN COVID-19 PNEUMONIA
[patent_app_type] => utility
[patent_app_number] => 18/041153
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041153
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041153 | USES OF MSC IN IMPROVING THROMBOTIC COMPLICATIONS IN COVID-19 PNEUMONIA | Aug 9, 2021 | Pending |
Array
(
[id] => 18829630
[patent_doc_number] => 20230398154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => A COMPOSITION COMPRISING MESENCHYMAL PRECURSOR OR STEM CELLS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/041303
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041303
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041303 | A COMPOSITION COMPRISING MESENCHYMAL PRECURSOR OR STEM CELLS AND THEIR USE | Aug 8, 2021 | Pending |